Active substanceInterferon GammaInterferon Gamma
Similar drugsTo uncover
  • Ingarone®
    lyophilizate nazal. 
    NPP FARMAKLON, LLC     Russia
  • Ingarone®
    lyophilizate w / m PC 
    NPP FARMAKLON, LLC     Russia
  • Dosage form: & nbsp
    lyophilizate for the preparation of a solution for intranasal administration
    Composition:

    Active substances: interferon gamma - 100000 ME (5.5 ± 0.5 μg).

    Excipients: mannitol.

    Description:The preparation is a loose or porous mass of white color, hygroscopic.
    Pharmacotherapeutic group:Immunostimulating agent
    ATX: & nbsp

    L.03.A.B.03   Interferon Gamma

    Pharmacodynamics:

    INGARON® - recombinant interferon gamma human, consists of 144 amino acid residues (aa), is deprived of the first three a. about. Cys-Tyr-Cys, replaced by Met. Molecular weight 16.9 kDa. It was obtained by microbiological synthesis in a recombinant strain of Escherichia coli and purified by column chromatography. Specific antiviral activity on cells (human fibroblasts) infected with vesicular stomatitis virus is 2 * 107 U / mg protein. Interferon Gamma (immune interferon) is the most important anti-inflammatory cytokine, the producers of which in the human body are natural killer cells, CD4 Th1 cells and CD8 cytotoxic suppressor cells. Receptors for interferon gamma have macrophages, neutrophils, natural killer cells, cytotoxic T-lymphocytes.Activates the effector functions of these cells, in particular their microbicide, cytotoxicity, their production of cytokines, superoxide and nitroxide radicals (thereby causing the death of intracellular parasites). Interferon Gamma blocks the replication of viral DNA and RNA, the synthesis of viral proteins and the assembly of mature viral particles. This causes a cytotoxic effect on the virus-infected cells.

    Inhibits the B-cell response to interleukin-4, inhibits the production of IgE and the expression of CD23 antigen. It is an inducer of apoptosis of differentiated B cells, giving rise to autoreactive clones. Suppresses the suppressive effect of interleukin-4 on interleukin-2-dependent proliferation and generation of lymphokine-activated killers. Activates the production of proteins of the acute phase of inflammation, enhances the expression of the C2 and C4 components of the complement system. Unlike other interferons, it increases the expression of MHC antigens of both the first and second classes on different cells, and induces the expression of these molecules even on those cells that do not express them constitutively. This improves the efficiency of antigen presentation and the ability to recognize them by T lymphocytes.

    Interferon gamma blocks the synthesis of β-TGF, responsible for the development of pulmonary fibrosis and liver.

    Indications:Prophylaxis and treatment (as part of complex therapy) of influenza. Prevention and treatment (as part of complex therapy) of influenza H5N1 and H1N1.
    Contraindications:Individual intolerance to interferon gamma or any other component of the drug. Pregnancy. Children's age (under 7 years).
    Dosing and Administration:

    Intranasal. The contents of the vial are dissolved in 5 ml of water for injection. At the first signs of the flu, ARVI 2 drops in each nasal passage after the toilet of the nasal passages 5 times a day for 5-7 days. For the prevention of acute respiratory viral infections and influenza, when in contact with the patient and / or during supercooling, 2-3 drops in each nasal passage every other day for 30 minutes before breakfast for 10 days. If necessary, preventive courses are repeated. When a single contact is enough, one instillation.

    After instillation it is recommended to massage the wings of the nose with your fingers for several minutes to distribute the drug evenly in the nasal cavity.

    Side effects:Not noted.
    Form release / dosage:Lyophilizate for the preparation of a solution for intranasal administration.
    Packaging:

    In vials of 100 000 ME per 1 bottle.

    For 1 vial of the drug complete with 1 ampoule of 5 ml solvent and with 1 lid-dropper from polyethylene in a polyethylene bag or by pipetting medical in a contour mesh package or in a cassette outline package.

    For 1 or 5 contour packs with instructions for use are packed in packs of cardboard.

    For 1 or 5 bottles of the drug in the kit, respectively, with 1 or 5 lids-droppers from polyethylene in a plastic bag or medical pipettes and instructions for use are packed in packs of cardboard.

    Storage conditions:

    In a dry place, protected from light and out of reach of children, at a temperature not exceeding + 25 ° C.

    The drug solution should not be stored for more than 10 days in the refrigerator (do not freeze).

    Shelf life:2 years. Do not use after the expiration date.
    Terms of leave from pharmacies:On prescription
    Registration number:LS-001330
    Date of registration:27.08.2010 / 26.07.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:NPP FARMAKLON, LLC NPP FARMAKLON, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp03.11.2017
    Illustrated instructions
      Instructions
      Up